Bacterial efflux pump inhibitors

US2021137881A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2021137881-A1
Application numberUS-201816492908-A
CountryUS
Kind codeA1
Filing dateMar 9, 2018
Priority dateMar 10, 2017
Publication dateMay 13, 2021
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are compounds of formula I: and salts thereof. Also disclosed are compositions comprising compounds of formula I and methods using compounds of formula I.

First claim

Opening claim text (preview).

1 . A compound of formula I: wherein: A is —C(═O)N(R a1 )—R 1 , —(C 1 -C 3 )alkyl-C(═O)N(R a1 )R 1 , —(C 1 -C 3 )alkyl-O —R 1 , —O—R 1 , —(C 1 -C 3 )alkyl-N(R a1 )—R 1 , or —N(R a1 )—R 1 ; each R 1 is independently a (C 3 -C 7 )carbocyclyl, (C 3 -C 7 )carbocyclyl-(C 1 -C 4 )alkyl-, 4-7 membered monocyclic heterocyclyl, or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl-, wherein each (C 3 -C 7 )carbocyclyl or (C 3 -C 7 )carbocyclyl-(C 1 -C 4 )alkyl- is independently substituted with one or more groups selected from the group consisting of Z and —(C 1 -C 6 )alkyl substituted with one or more Z, and wherein each 4-7 membered monocyclic heterocyclyl or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl- is independently optionally substituted with one or more groups selected from the group consisting of Z and —(C 1 -C 6 )alkyl substituted with one or more Z, wherein each Z is independently selected from the group consisting of NR b2 R c2 , —NHNH 2 , —C(═NR a2 )(NR b2 R c2 ), —NR a2 C(═NR a2 )(R d2 ), and —NR a2 C(═NR a2 )(NR b2 R c2 ) and wherein each (C 3 -C 7 )carbocyclyl, (C 3 -C 7 )carbocyclyl-(C 1 -C 4 )alkyl-, 4-7 membered monocyclic heterocyclyl, or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl-, is independently optionally substituted independently with one or more (C 1 -C 4 )alkyl; R 2 is hydrogen, halo, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkoxy, aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy and (C 1 -C 4 )haloalkoxy; R 3 is hydrogen, halo, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy, (C 1 -C 4 )haloalkoxy, aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy; R 4 is hydrogen, halo, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy, (C 1 -C 4 )haloalkoxy, aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy; R 5 is hydrogen, halo, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy, (C 1 -C 4 )haloalkoxy, aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy; R 6 is hydrogen, halo, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkoxy, aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy and C 1 -C 4 )haloalkoxy; each R a1 is independently hydrogen, (C 1 -C 6 )alkyl or (C 3 -C 7 )carbocyclyl; each R a2 is independently hydrogen, (C 1 -C 6 )alkyl or (C 3 -C 7 )carbocyclyl; each R b2 and R c2 is independently hydrogen, (C 1 -C 6 )alkyl or (C 3 -C 7 )carbocyclyl; and R d2 is (C 1 -C 6 )alkyl or (C 3 -C 7 )carbocyclyl; or a salt thereof. 2 . The compound or salt of claim 1 , wherein A is —C(═O)N(R a1 )—R 1 , —(C 1 -C 3 )alkyl-C(═O)N(R a1 )R 1 , —(C 1 -C 3 )alkyl-O —R 1 , or —O—R 1 . 3 . The compound or salt of claim 1 , wherein A is —C(═O)N(R a1 )—R 1 . 4 . The compound or salt of claim 1 , wherein A is —(C 1 -C 3 )alkyl-C(═O)N(R a1 )R 1 . 5 . The compound or salt of any one of claims 1 - 4 , wherein R a1 is hydrogen. 6 . The compound or salt of claim 1 , wherein A is —O—R 1 . 7 . The compound or salt of any one of claims 1 - 6 , wherein R 2 is hydrogen, halo, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy, or (C 1 -C 4 )haloalkoxy. 8 . The compound or salt of any one of claims 1 - 6 , wherein R 2 is hydrogen. 9 . The compound or salt of any one of claims 1 - 8 , wherein R 3 is aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy. 10 . The compound or salt of any one of claims 1 - 8 , wherein R 3 is phenyl wherein the phenyl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy. 11 . The compound or salt of any one of claims 1 - 8 , wherein R 3 is 4-fluorophenyl or 4-trifluoromethyphenyl. 12 . The compound or salt of any one of claims 1 - 6 , wherein R 4 is hydrogen, halo, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy, (C 1 -C 4 )haloalkoxy. 13 . The compound or salt of any one of claims 1 - 6 , wherein R 4 is hydrogen. 14 . The compound or salt of any one of claims 1 - 13 , wherein R 5 is aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy. 15 . The compound or salt of any one of claims 1 - 13 , wherein R 5 is phenyl wherein the phenyl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy. 16 . The compound or salt of any one of claims 1 - 13 , wherein R 5 is 4-fluorophenyl or 4-trifluoromethyphenyl. 17 . The compound or salt of any one of claims 1 - 16 , wherein R 6 is hydrogen, halo, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy, or (C 1 -C 4 )haloalkoxy. 18 . The compound or salt of any one of claims 1 - 16 , wherein R 6 is hydrogen. 19 . The compound or salt of any one of claims 1 - 6 , wherein the moiety: of the compound of formula I is: 20 . The compound or salt of any one of claims 1 - 17 , wherein R 1 is a 4-7 membered monocyclic heterocyclyl or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl-, wherein the 4-7 membered monocyclic heterocyclyl or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl- is optionally substituted independently with one or more groups selected from the group consisting of Z and —(C 1 -C 6 )alkyl substituted with one or more Z, wherein each Z is NR b2 R c2 nd wherein the 4-7 membered monocyclic heterocyclyl or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl- is optionally substituted with one or more (C 1 -C 4 )alkyl. 21 . The compound or salt of any one of claims 1 - 17 , wherein R 1 is a 4-7 membered monocyclic N-heterocyclyl or 4-7 membered monocyclic N-heterocyclyl-(C 1 -C 4 )alkyl-, wherein the 4-7 membered monocyclic N-heterocyclyl or 4-7 membered monocyclic N-heterocyclyl-(C 1 -C 4 )alkyl- is optionally substituted independently with one or more groups selected from the group consisting of Z and —(C 1 -C

Assignees

Inventors

Classifications

  • A61K31/40Primary

    having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil · CPC title

  • Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title

  • Oxygen or sulfur atoms · CPC title

  • Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose · CPC title

  • Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2021137881A1 cover?
Disclosed herein are compounds of formula I: and salts thereof. Also disclosed are compositions comprising compounds of formula I and methods using compounds of formula I.
Who is the assignee on this patent?
Univ Rutgers, Rutgers The State Univeristy Of New Jersey
What technology area does this patent fall under?
Primary CPC classification A61K31/40. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu May 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).